| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |